Showing results (11-20 of 617) with videos related to
Sort By:
Pageof 62
Cell Metabolism|August 11, 2016
Empagliflozin's Fuel Hypothesis: Not so SoonGary D Lopaschuk, Subodh VermaAmerican Journal of Physiology. Heart and Circulatory Physiology|January 18, 2005
Antiatherogenic potential of red wine: clinician updatePaul E Szmitko, Subodh VermaJACC. Basic to Translational Science|July 3, 2020
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art ReviewGary D Lopaschuk, Subodh VermaAtherosclerosis|April 29, 2008
The endocannabinoid system and cardiometabolic riskPaul E Szmitko, Subodh VermaThe Canadian Journal of Cardiology|February 25, 2006
The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosisSubodh Verma, Paul E SzmitkoCurrent Opinion in Cardiology|November 23, 2016
Functional mitral stenosis following mitral valve repairVincent Chan, Thierry Mesana, Subodh VermaProgress in Cardiovascular Diseases|August 6, 2019
Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetesVinay Garg, Subodh Verma, Kim ConnellyCurrent Opinion in Cardiology|January 6, 2016
Update on rheumatic heart diseaseBobby Yanagawa, Jagdish Butany, Subodh VermaCurrent Opinion in Cardiology|January 28, 2016
Year in review: mitral valve surgeryBobby Yanagawa, David Latter, Subodh VermaCurrent Opinion in Cardiology|December 22, 2018
Early failure of aortic bioprostheses: what are the mechanisms?Amine Mazine, Subodh Verma, Bobby YanagawaPageof 62